Your browser doesn't support javascript.
loading
Hyperprogressive Disease After Pembrolizumab Treatment in Advanced Epstein-Barr Virus-Associated Gastric Adenocarcinoma With ERBB2 Amplification.
Watson, Sarah; Cyrta, Joanna; Lefevre, Marine; Planchon, Julien Masliah; Louvet, Christophe; Servois, Vincent; Vaflard, Pauline; Bidard, François Clément; Bieche, Ivan; Soularue, Emilie.
Afiliação
  • Watson S; Institut Curie, PSL Research University, Department of Medical Oncology, Paris, France.
  • Cyrta J; Institut Curie, PSL Research University, INSERM U830, Cancer, Heterogeneity, Instability and Plasticity (CHIP), Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France.
  • Lefevre M; Institut Curie, PSL Research University, Department of Pathology, Paris, France.
  • Planchon JM; Institut Mutualiste Montsouris, Department of Pathology, Paris, France.
  • Louvet C; Institut Curie, PSL Research University, Department of Genetics, Paris, France.
  • Servois V; Institut Mutualiste Montsouris, Department of Medical Oncology, Paris, France.
  • Vaflard P; Institut Curie, PSL Research University, Department of Radiology, Paris, France.
  • Bidard FC; Institut Curie, PSL Research University, Department of Medical Oncology, Paris, France.
  • Bieche I; Institut Curie, UVSQ and Paris Saclay University, Saint Cloud, France.
  • Soularue E; Institut Curie, PSL Research University, Department of Genetics, Paris, France.
JCO Precis Oncol ; 5: 370-377, 2021 11.
Article em En | MEDLINE | ID: mdl-34994599
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Inibidores de Checkpoint Imunológico Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Adenocarcinoma / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Inibidores de Checkpoint Imunológico Tipo de estudo: Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article